The BD MAX Respiratory Viral Panel uses a single nasal or nasopharyngeal swab sample to determine if a patient has COVID-19, the flu or RSV. – BD Patients wondering whether they have COVID-19 ...

Development of the BD Respiratory Viral Panel assay for BD Max System was financed in whole or in part with federal funds from the Department of Health and Human Services; Office of the ...

WebMD's Chief Medical Officer, John Whyte, MD, speaks with Brian Caveney, MD, President & Chief Medical Officer, Labcorp Diagnostics, about a new EUA test that can differentiate between COVID-19 ...

(RTTNews) - Becton, Dickinson and Company (BDX) announced the BD MAX Respiratory Viral Panel, a combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus, has been CE marked ...

The Idylla™ Respiratory IFV-RSV Panel is designed for the qualitative detection of nucleic acids of Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype 2009 H1, H275Y ...

AUGUSTA, Ga. (Nov. 1, 2021) – With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous ...

The molecular panel—which screens for COVID-19, respiratory syncytial virus and influenza A and B from a single swab—is designed to deliver a result in two hours using the company’s ...

Luminex Corporation has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its xTAG™ Respiratory Viral Panel (RVP). xTAG RVP is said to be the first ...